phosphotyrosine has been researched along with Bladder Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Destefanis, P; Ferru, E; Fontana, D; Khadjavi, A; Mannu, F; Notarpietro, A; Pantaleo, A; Turrini, F | 1 |
| Chen, SY; Chiu, HY; Jwo, SC; Lee, MY; Sun, GH; Sun, KH; Tang, SJ; Tsou, YC; Wang, HH | 1 |
| Boyce, T; Clack, G; Duffield, E; Fennell, M; Green, T; Jacobs, V; Jones, RJ; Kelly, J; Pinto, F; Robertson, J | 1 |
| Chow, N; Lai, M; Su, S; Yeh, T | 1 |
1 trial(s) available for phosphotyrosine and Bladder Cancer
| Article | Year |
|---|---|
A high-throughput assay for the detection of Tyr-phosphorylated proteins in urine of bladder cancer patients.
Topics: Aged; Biomarkers, Tumor; Female; Humans; Male; Middle Aged; Phosphoproteins; Phosphorylation; Phosphotyrosine; Urinary Bladder Neoplasms | 2013 |
3 other study(ies) available for phosphotyrosine and Bladder Cancer
| Article | Year |
|---|---|
Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
Topics: Animals; Autocrine Communication; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Chemokine CCL2; Enzyme Activation; Female; Gene Knockdown Techniques; Humans; Mice; Neoplasm Invasiveness; Paxillin; Phosphorylation; Phosphotyrosine; Protein Kinase C; Receptors, CCR2; Urinary Bladder Neoplasms | 2012 |
The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers.
Topics: Aged; Aged, 80 and over; Biomarkers; Biopsy; Breast Neoplasms; Female; Focal Adhesion Protein-Tyrosine Kinases; Freezing; Humans; Immunoassay; Male; Middle Aged; Paxillin; Phosphorylation; Phosphotyrosine; src-Family Kinases; Time Factors; Tissue Fixation; Urinary Bladder Neoplasms | 2008 |
Overexpression of HER-2/neu enhances the sensitivity of human bladder cancer cells to urinary isoflavones.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Division; Down-Regulation; Gene Expression; Genes, erbB-2; Glycine max; Humans; Isoflavones; Phosphotyrosine; Phytotherapy; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2001 |